Amedeo Smart

Free Medical Literature Service


 

Amedeo

Colorectal Neoplasms

  Free Subscription

Articles published in
Ann Surg Oncol
    August 2021
  1. VERTER E, Berger Y, Perl G, Peretz I, et al
    Neutrophil-to-Lymphocyte Ratio Predicts Recurrence Pattern in Patients with Resectable Colorectal Liver Metastases.
    Ann Surg Oncol. 2021;28:4320-4329.
    >> Share

  2. RAMANATHAN R, Choudry H, Jones H, Girgis M, et al
    Phase II Trial of Adjuvant Dendritic Cell Vaccine in Combination with Celecoxib, Interferon-alpha, and Rintatolimod in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases.
    Ann Surg Oncol. 2021;28:4637-4646.
    >> Share

  3. KOBAYASHI S, Nakamura Y, Taniguchi H, Odegaard JI, et al
    Impact of Preoperative Circulating Tumor DNA Status on Survival Outcomes After Hepatectomy for Resectable Colorectal Liver Metastases.
    Ann Surg Oncol. 2021;28:4744-4755.
    >> Share

  4. VERTER E, Berger Y, Perl G, Peretz I, et al
    ASO Visual Abstract: Neutrophil-to-Lymphocyte Ratio Predicts Recurrence Pattern in Patients with Resectable Colorectal Liver Metastases.
    Ann Surg Oncol. 2021;28:4332-4333.
    >> Share

  5. KHAN TM, Verbus EA, Rehman SU, Chun YS, et al
    The Role of Liver Resection for Patients with Liver and Unresectable Lung Colorectal Metastases (LUNA).
    Ann Surg Oncol. 2021;28:4102-4103.
    >> Share

  6. VERTER E, Sadot E
    ASO Author Reflections: Neutrophil-to-Lymphocyte Ratio Predicts Recurrence Pattern in Patients with Resectable Colorectal Liver Metastases.
    Ann Surg Oncol. 2021;28:4330-4331.
    >> Share

  7. BEAL EW, Cloyd JM
    Neutrophil-to-Lymphocyte Ratio in Colorectal Liver Metastases: Simply Prognostic or Clinically Relevant?
    Ann Surg Oncol. 2021;28:4072-4073.
    >> Share

  8. KOBAYASHI S, Nakamura Y, Takahashi S, Taniguchi H, et al
    ASO Author Reflections: Circulating Tumor DNA (ctDNA) as a Potentially Practice-Changing Innovation to Evolve "Precision Onco-Surgery" in Resectable Colorectal Liver Metastases.
    Ann Surg Oncol. 2021;28:4756-4757.
    >> Share

    July 2021
  9. NAGATA K, Shinto E, Shiraishi T, Yamadera M, et al
    Mesothelin Expression is Correlated with Chemoresistance in Stage IV Colorectal Cancer.
    Ann Surg Oncol. 2021 Jul 27. pii: 10.1245/s10434-021-10507.
    >> Share

  10. MOR E, Assaf D, Laks S, Benvenisti H, et al
    ASO Visual Abstract: Ratio of Pathological Response to Preoperative Chemotherapy in Patients Undergoing Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer Correlates with Survival.
    Ann Surg Oncol. 2021 Jul 20. pii: 10.1245/s10434-021-10410.
    >> Share

  11. LI YJ, Yang CN, Kuo MY, Lai WT, et al
    ASO Visual Abstract: ATMIN Suppresses Metastasis by Altering the WNT Signaling Pathway via PARP1 in MSI-High Colorectal Cancer.
    Ann Surg Oncol. 2021 Jul 15. pii: 10.1245/s10434-021-10388.
    >> Share

  12. JOHNSTON FM, Yeo HL, Clark C, Stewart JH 4th, et al
    ASO Visual Abstract: Bias Issues in Colorectal Cancer Management-A Review.
    Ann Surg Oncol. 2021 Jul 14. pii: 10.1245/s10434-021-10252.
    >> Share

  13. MOR E, Assaf D, Laks S, Benvenisti H, et al
    Ratio of Pathological Response to Preoperative Chemotherapy in Patients Undergoing Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer Correlates with Survival.
    Ann Surg Oncol. 2021 Jul 7. pii: 10.1245/s10434-021-10367.
    >> Share

  14. RIESER CJ, Hoehn RS, Zenati M, Hall LB, et al
    Impact of Socioeconomic Status on Presentation and Outcomes in Colorectal Peritoneal Metastases Following Cytoreduction and Chemoperfusion: Persistent Inequalities in Outcomes at a High-Volume Center.
    Ann Surg Oncol. 2021;28:3522-3531.
    >> Share

  15. LIU W, Zhang ZY, Yin SS, Yan K, et al
    Contrast-Enhanced Intraoperative Ultrasound Improved Sensitivity and Positive Predictive Value in Colorectal Liver Metastasis: a Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2021;28:3763-3773.
    >> Share

  16. BHATT A, Rousset P, Benzerdjeb N, Kammar P, et al
    Clinical and Radiologic Predictors of a Pathologic Complete Response to Neoadjuvant Chemotherapy (NACT) in Patients Undergoing Cytoreductive Surgery for Colorectal Peritoneal Metastases: Results of a Prospective Multi-center Study.
    Ann Surg Oncol. 2021;28:3840-3849.
    >> Share

  17. LI YJ, Yang CN, Kuo YP, Lai WT, et al
    ASO Author Reflections: ATMIN Altering the WNT Signaling Pathway via PARP1 in MSI-High Colorectal Cancer.
    Ann Surg Oncol. 2021 Jul 1. pii: 10.1245/s10434-021-10391.
    >> Share

  18. TAKAHASHI H, Takemasa I, Miyoshi N, Uemura M, et al
    ASO Visual Abstract: Application of Local Hyaluronic Acid Injection in Transanal Minimally Invasive Surgery for Anterior Rectal GIST.
    Ann Surg Oncol. 2021;28:3775-3776.
    >> Share

  19. TAKAHASHI H, Takemasa I, Doki Y, Eguchi H, et al
    ASO Author Reflections: Opening up the Future with Transanal Minimally Invasive Surgery of Fine Techniques.
    Ann Surg Oncol. 2021;28:3777-3778.
    >> Share

  20. CHAKRABARTI D, Akhtar N, Rajan S, Qayoom S, et al
    Intensifying Neoadjuvant Therapy for Rectal Cancers Towards Watchful Waiting.
    Ann Surg Oncol. 2021;28:4062-4063.
    >> Share

  21. TAKAHASHI H, Takemasa I, Miyoshi N, Uemura M, et al
    Application of Local Hyaluronic Acid Injection in Transanal Minimally Invasive Surgery for Anterior Rectal GIST.
    Ann Surg Oncol. 2021;28:3774.
    >> Share

  22. HUISMAN JF, Schoenaker IJH, Brohet RM, de Vos Tot Nederveen Cappel WH, et al
    Reply to "Intensifying Neoadjuvant Therapy for Rectal Cancers Towards Watchful Waiting," by Chakrabarti, Deep, et al.
    Ann Surg Oncol. 2021;28:4064-4065.
    >> Share

  23. BHATT A, Kepenekian V, Benzerdjeb N, Glehen O, et al
    ASO Author Reflections: Potential Therapeutic Implications and Prediction of Pathological Complete Response to Systemic Chemotherapy in Colorectal Peritoneal Metastases.
    Ann Surg Oncol. 2021;28:3850-3851.
    >> Share

    June 2021
  24. MOR E, Laks S, Nissan A, Adileh M, et al
    ASO Author Reflections: Pathologic Response Ratio (PRR) in CRS and HIPEC for Peritoneal Metastasis from Colorectal Cancer.
    Ann Surg Oncol. 2021 Jun 27. pii: 10.1245/s10434-021-10369.
    >> Share

  25. MCINTYRE C, Yeo HL, Clark C, Stewart JH 4th, et al
    ASO Author Reflections: Colorectal Cancer, Bias, and the Surgeon: What is Next?
    Ann Surg Oncol. 2021 Jun 21. pii: 10.1245/s10434-021-10264.
    >> Share

  26. LI YJ, Yang CN, Kuo MY, Lai WT, et al
    ATMIN Suppresses Metastasis by Altering the WNT-Signaling Pathway via PARP1 in MSI-High Colorectal Cancer.
    Ann Surg Oncol. 2021 Jun 19. pii: 10.1245/s10434-021-10322.
    >> Share

  27. JOHNSTON FM, Yeo HL, Clark C, Stewart JH 4th, et al
    Bias Issues in Colorectal Cancer Management: A Review.
    Ann Surg Oncol. 2021 Jun 17. pii: 10.1245/s10434-021-10232.
    >> Share

  28. DIAZ-VICO T, Fernandez-Hevia M, Suarez-Sanchez A, Garcia-Gutierrez C, et al
    Complete Mesocolic Excision and D3 Lymphadenectomy versus Conventional Colectomy for Colon Cancer: A Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2021 Jun 4. pii: 10.1245/s10434-021-10186.
    >> Share

  29. TANI K, Itabashi M, Okuya K, Okita K, et al
    Feasibility of Pooled One-Step Nucleic Acid Amplification for Molecular Staging of Pathologically Node-Negative Colon Cancer: A Prospective Multicenter Study.
    Ann Surg Oncol. 2021 Jun 4. pii: 10.1245/s10434-021-10140.
    >> Share

  30. NAKANISHI R, Oki E, Hasuda H, Sano E, et al
    Radiomics Texture Analysis for the Identification of Colorectal Liver Metastases Sensitive to First-Line Oxaliplatin-Based Chemotherapy.
    Ann Surg Oncol. 2021;28:2975-2985.
    >> Share

  31. QWAIDER YZ, Sell NM, Stafford CE, Kunitake H, et al
    Infiltrating Tumor Border Configuration is a Poor Prognostic Factor in Stage II and III Colon Adenocarcinoma.
    Ann Surg Oncol. 2021;28:3408-3414.
    >> Share

  32. NAKANISHI R, Oki E, Hasuda H, Sano E, et al
    ASO Author Reflection: Radiomics-Based Prediction for the Responder to First-Line Oxaliplatin-Based Chemotherapy in Patients with Colorectal Liver Metastasis.
    Ann Surg Oncol. 2021;28:2986-2987.
    >> Share

  33. HEWITT DB, Pawlik TM, Cloyd JM
    Who Will Benefit? Using Radiomics to Predict Response to Oxaliplatin-Based Chemotherapy in Patients with Colorectal Liver Metastases.
    Ann Surg Oncol. 2021;28:2931-2933.
    >> Share

    May 2021
  34. ROSSI AJ, Khan TM, Rehman SU, Nash GM, et al
    Early Postoperative Intraperitoneal Versus Hyperthermic Intraperitoneal Chemotherapy After Optimal Cytoreductive Surgery for Colorectal Cancer with Isolated Peritoneal Metastasis (ICARuS).
    Ann Surg Oncol. 2021 May 25. pii: 10.1245/s10434-021-10110.
    >> Share

  35. VERBUS EA, Rossi AJ, Luna AJ, Iqbal A, et al
    Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy for Patients with Stage 2A Colon Cancer (COBRA).
    Ann Surg Oncol. 2021 May 17. pii: 10.1245/s10434-021-10112.
    >> Share

  36. ROSSI AJ, Khan TM, Hong H, Lesinski GB, et al
    Pepinemab (Anti-SEMA4D) in Combination with Ipilimumab or Nivolumab for Patients with Resectable Pancreatic and Colorectal Cancer.
    Ann Surg Oncol. 2021 May 13. pii: 10.1245/s10434-021-10111.
    >> Share

  37. BIJELIC L, Ramos I, Goere D
    The Landmark Series: Surgical Treatment of Colorectal Cancer Peritoneal Metastases.
    Ann Surg Oncol. 2021 May 9. pii: 10.1245/s10434-021-10049.
    >> Share

  38. VAN LOON YT, Stassen LPS, Zimmerman DDE
    ASO Author Reflections: Nationwide Data on Ostomy Use in Elderly Patients After Colorectal Cancer Surgery.
    Ann Surg Oncol. 2021 May 6. pii: 10.1245/s10434-021-10057.
    >> Share

  39. HUISMAN JF, Schoenaker IJH, Brohet RM, Reerink O, et al
    Avoiding Unnecessary Major Rectal Cancer Surgery by Implementing Structural Restaging and a Watch-and-Wait Strategy After Neoadjuvant Radiochemotherapy.
    Ann Surg Oncol. 2021;28:2811-2818.
    >> Share

  40. D'ALIMONTE L, Bao QR, Spolverato G, Capelli G, et al
    Long-Term Outcomes of Local Excision Following Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
    Ann Surg Oncol. 2021;28:2801-2808.
    >> Share

  41. SPENCE RT, Hirpara DH, Doshi S, Quereshy FA, et al
    Will My Patient Survive an Anastomotic Leak? Predicting Failure to Rescue Using the Modified Frailty Index.
    Ann Surg Oncol. 2021;28:2779-2787.
    >> Share

  42. BAO QR, Capelli G, Spolverato G, Pucciarelli S, et al
    ASO Author Reflections: Local Excision Following Neoadjuvant Therapy for Rectal Cancer: A Compromise Between TME and Watch-and-Wait in Patients with Major Response.
    Ann Surg Oncol. 2021;28:2809-2810.
    >> Share

    April 2021
  43. O'CONNELL E, Salvucci M, Reynolds IS, McNamara DA, et al
    Mucinous Colorectal Cancer is Associated With Expression of the TIM-3 Immune Checkpoint Independently of Microsatellite Instability (MSI) Status.
    Ann Surg Oncol. 2021 Apr 19. pii: 10.1245/s10434-021-09873.
    >> Share

  44. WU Q, Gu C, Wang Z
    Comment on: Repeat Cytoreductive Surgery and Intraperitoneal Chemotherapy for Colorectal Cancer Peritoneal Recurrences Is Safe and Efficacious.
    Ann Surg Oncol. 2021 Apr 16. pii: 10.1245/s10434-021-09930.
    >> Share

  45. LAKS S, Ben-Yaacov A, Adileh M, Nissan A, et al
    Authors' Reply to Wu et al. "Comment on: Repeat Cytoreductive Surgery and Intraperitoneal Chemotherapy for Colorectal Cancer Peritoneal Recurrences is Safe and Efficacious".
    Ann Surg Oncol. 2021 Apr 3. pii: 10.1245/s10434-021-09933.
    >> Share

  46. CHAO YK
    Is It Time to Add Tumor Regression Grade into the ypN Category?
    Ann Surg Oncol. 2021;28:1880-1881.
    >> Share

  47. DOKMAK S, Aussilhou B, Levenson G, Guarneri G, et al
    Staged Double Hepatectomy, Double Total Vascular Exclusion, and Double Venous Reconstruction by Peritoneal Patches in One Patient with Colorectal Liver Metastases.
    Ann Surg Oncol. 2021;28:2028-2029.
    >> Share

  48. TRUANT S, Baillet C, Gnemmi V, Fulbert M, et al
    The Impact of Modern Chemotherapy and Chemotherapy-Associated Liver Injuries (CALI) on Liver Function: Value of 99mTc-Labelled-Mebrofenin SPECT-Hepatobiliary Scintigraphy.
    Ann Surg Oncol. 2021;28:1959-1969.
    >> Share

    March 2021
  49. MUADDI H, Silva S, Choi WJ, Coburn N, et al
    When is a Ghost Really Gone? A Systematic Review and Meta-analysis of the Accuracy of Imaging Modalities to Predict Complete Pathological Response of Colorectal Cancer Liver Metastases After Chemotherapy.
    Ann Surg Oncol. 2021 Mar 26. pii: 10.1245/s10434-021-09824.
    >> Share

  50. SQUEO GC, Kane WJ, Hedrick TL
    Guide to Enhanced Recovery for Cancer Patients Undergoing Surgery: ERP and Colorectal Cancer Surgery.
    Ann Surg Oncol. 2021 Mar 17. pii: 10.1245/s10434-021-09802.
    >> Share

  51. CHAVEZ MI, Gholami S, Kim BJ, Margonis GA, et al
    Two-Stage Hepatectomy for Bilateral Colorectal Liver Metastases: A Multi-institutional Analysis.
    Ann Surg Oncol. 2021;28:1457-1465.
    >> Share

  52. DIXON MEB, Gusani NJ
    Bilobar Colorectal Liver Metastases: Challenges and Opportunities.
    Ann Surg Oncol. 2021;28:1268-1270.
    >> Share

  53. GAMBOA AC, Lee RM, Turgeon MK, Varlamos C, et al
    Impact of Postoperative Complications on Oncologic Outcomes After Rectal Cancer Surgery: An Analysis of the US Rectal Cancer Consortium.
    Ann Surg Oncol. 2021;28:1712-1721.
    >> Share

    February 2021
  54. LAKS S, Schtrechman G, Adileh M, Ben-Yaacov A, et al
    Repeat Cytoreductive Surgery and Intraperitoneal Chemotherapy for Colorectal Cancer Peritoneal Recurrences is Safe and Efficacious.
    Ann Surg Oncol. 2021 Feb 16. pii: 10.1245/s10434-021-09684.
    >> Share

  55. BATCHELOR T, Hasan J, Macbeth F, Shackcloth M, et al
    Randomised Controlled Trial Evidence Questions the Assumption that Pulmonary Metastasectomy Benefits Patients with Colorectal Cancer.
    Ann Surg Oncol. 2021 Feb 15. pii: 10.1245/s10434-020-09521.
    >> Share

  56. ADILEH M, Yuval JB, Walch HS, Chatila WK, et al
    Primary Tumor Location and Outcomes After Cytoreductive Surgery and Intraperitoneal Chemotherapy for Peritoneal Metastases of Colorectal Origin.
    Ann Surg Oncol. 2021;28:1109-1117.
    >> Share

  57. VANOLI A, Grillo F, Guerini C, Neri G, et al
    Prognostic Role of Mismatch Repair Status, Histotype and High-Risk Pathologic Features in Stage II Small Bowel Adenocarcinomas.
    Ann Surg Oncol. 2021;28:1167-1177.
    >> Share

  58. DE BELLIS M, Vega EA, Kawaguchi Y, Panettieri E, et al
    Simultaneous Sigmoid Colectomy, Bilobar Liver Resection and Lung Metastasectomy via a Transdiaphragmatic Approach for Stage IV Colonic Adenocarcinoma.
    Ann Surg Oncol. 2021;28:863-864.
    >> Share

  59. SAADAT LV, Boerner T, Goldman DA, Gonen M, et al
    Association of RAS Mutation Location and Oncologic Outcomes After Resection of Colorectal Liver Metastases.
    Ann Surg Oncol. 2021;28:817-825.
    >> Share

  60. BUISMAN FE, Filipe WF, Kemeny NE, Narayan RR, et al
    Recurrence After Liver Resection of Colorectal Liver Metastases: Repeat Resection or Ablation Followed by Hepatic Arterial Infusion Pump Chemotherapy.
    Ann Surg Oncol. 2021;28:808-816.
    >> Share

    January 2021
  61. PAKU M, Haraguchi N, Takeda M, Fujino S, et al
    SIRT3-Mediated SOD2 and PGC-1alpha Contribute to Chemoresistance in Colorectal Cancer Cells.
    Ann Surg Oncol. 2021 Jan 3. pii: 10.1245/s10434-020-09373.
    >> Share

  62. LURVINK RJ, Tajzai R, Rovers KP, Wassenaar ECE, et al
    Systemic Pharmacokinetics of Oxaliplatin After Intraperitoneal Administration by Electrostatic Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC) in Patients with Unresectable Colorectal Peritoneal Metastases in the CRC-PIPAC Trial.
    Ann Surg Oncol. 2021;28:265-272.
    >> Share

    December 2020
  63. PAREDES AZ, Tsilimigras DI, Pawlik TM
    ASO Author Reflections: Development and Validation of a Novel Risk Score Using Machine-Learning Methodology to Predict Recurrence After Hepatectomy for Colorectal Liver Metastases.
    Ann Surg Oncol. 2020;27:5148-5149.
    >> Share

    November 2020
  64. ALONSO S, Saltz L
    The Landmark Series: Chemotherapy for Non-Metastatic Colon Cancer.
    Ann Surg Oncol. 2020 Nov 23. pii: 10.1245/s10434-020-09375.
    >> Share

  65. GHOLAMI S, Stewart S, Kemeny N, Gonen M, et al
    Impact of Primary Tumor Laterality on Adjuvant Hepatic Artery Infusion Pump Chemotherapy in Resected Colon Cancer Liver Metastases: Analysis of 487 Patients.
    Ann Surg Oncol. 2020 Nov 23. pii: 10.1245/s10434-020-09369.
    >> Share

  66. YAJIMA S, Suzuki T, Oshima Y, Shiratori F, et al
    New Assay System Elecsys Anti-p53 to Detect Serum Anti-p53 Antibodies in Esophageal Cancer Patients and Colorectal Cancer Patients: Multi-institutional Study.
    Ann Surg Oncol. 2020 Nov 18. pii: 10.1245/s10434-020-09342.
    >> Share

  67. QWAIDER YZ, Berger DL
    ASO Author Reflections: Prognostic Value of Tumor Border Configuration in Colon Cancer.
    Ann Surg Oncol. 2020 Nov 4. pii: 10.1245/s10434-020-09321.
    >> Share

  68. LUO W, Lu T, Xiao Y, Li F, et al
    A New Medial-to-Lateral Approach for Laparoscopic D3 Lymphadenectomy plus Complete Mesocolic Excision (D3 + CME) for Right-Sided Colon Cancer.
    Ann Surg Oncol. 2020 Nov 1. pii: 10.1245/s10434-020-09264.
    >> Share

    October 2020
  69. BOEDING JRE, Ramphal W, Rijken AM, Crolla RMPH, et al
    A Systematic Review Comparing Emergency Resection and Staged Treatment for Curable Obstructing Right-Sided Colon Cancer.
    Ann Surg Oncol. 2020 Oct 16. pii: 10.1245/s10434-020-09124.
    >> Share

  70. WANG J, Serrano PE, Griffiths C, Parpia S, et al
    Enthusiasm, Opinion Leaders, Comparative Advantage, and the Uptake Of Laparoscopic Resection For Colorectal Cancer Liver Metastases in Ontario, Canada: A Population-Based Cohort Study.
    Ann Surg Oncol. 2020 Oct 15. pii: 10.1245/s10434-020-09203.
    >> Share

  71. BARATTI D, Deraco M
    ASO Author Reflections: Prognostic Factors in Surgically Treated Peritoneal Metastases from Colorectal Cancer.
    Ann Surg Oncol. 2020 Oct 15. pii: 10.1245/s10434-020-09198.
    >> Share

  72. DE VALK KS, Deken MM, Schaap DP, Meijer RP, et al
    Dose-Finding Study of a CEA-Targeting Agent, SGM-101, for Intraoperative Fluorescence Imaging of Colorectal Cancer.
    Ann Surg Oncol. 2020 Oct 9. pii: 10.1245/s10434-020-09069.
    >> Share

  73. MOR E, Adileh M, Ariche A, Nissan A, et al
    ASO Author Reflections: Synchronous Liver and Peritoneal Metastasis From Colorectal Cancer.
    Ann Surg Oncol. 2020 Oct 1. pii: 10.1245/s10434-020-09186.
    >> Share

  74. HUANG WS, Kuan FC, Lin MH, Chen MF, et al
    Prognostic Significance of Neoadjuvant Rectal Scores in Preoperative Short-Course Radiotherapy and Long-Course Concurrent Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer.
    Ann Surg Oncol. 2020;27:4309-4318.
    >> Share

  75. HOENDERVANGERS S, Burbach JPM, Lacle MM, Koopman M, et al
    Pathological Complete Response Following Different Neoadjuvant Treatment Strategies for Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis.
    Ann Surg Oncol. 2020;27:4319-4336.
    >> Share

  76. SAMMOUR T, Bedrikovetski S
    Radiomics for Diagnosing Lateral Pelvic Lymph Nodes in Rectal Cancer: Artificial Intelligence Enabling Precision Medicine?
    Ann Surg Oncol. 2020;27:4082-4083.
    >> Share

  77. NAKANISHI R, Akiyoshi T
    ASO Author Reflections: CT-Based Radiomics Model to Predict Lateral Lymph Node Metastasis After Neoadjuvant (Chemo)Radiotherapy in Advanced Low Rectal Cancer.
    Ann Surg Oncol. 2020;27:4284-4285.
    >> Share

  78. KAWAGUCHI Y, Vauthey JN
    ASO Author Reflections: The Landmark Series: Randomized Control Trials Examining Perioperative Chemotherapy and Postoperative Adjuvant Chemotherapy for Resectable Colorectal Liver Metastasis.
    Ann Surg Oncol. 2020;27:4271-4272.
    >> Share

  79. DOUSSOT A, Lakkis Z
    ASO Author Reflections: Challenges in the Management of Synchronous Prostate Cancer and Rectal Cancer: Towards Double Organ Preservation?
    Ann Surg Oncol. 2020;27:4294-4295.
    >> Share

    September 2020
  80. BARATTI D, Kusamura S, Niger M, Perrone F, et al
    Prognostic Impact of Primary Side and RAS/RAF Mutations in a Surgical Series of Colorectal Cancer with Peritoneal Metastases.
    Ann Surg Oncol. 2020 Sep 24. pii: 10.1245/s10434-020-09161.
    >> Share

  81. ADILEH M, Mor E, Assaf D, Benvenisti H, et al
    Perioperative and Oncological Outcomes of Combined Hepatectomy with Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer.
    Ann Surg Oncol. 2020 Sep 23. pii: 10.1245/s10434-020-09165.
    >> Share

  82. MARGONIS GA, Andreatos N, Kreis ME, D'Angelica M, et al
    The Interplay of Primary Tumor Location and KRAS Mutation Status in Patients with Synchronous Colorectal Cancer Liver Metastases: Current Data and Unanswered Questions.
    Ann Surg Oncol. 2020 Sep 21. pii: 10.1245/s10434-020-09144.
    >> Share

  83. KLOSE J, Kloor M, Warschkow R, Antony P, et al
    Does Side Really Matter? Survival Analysis among Patients with Right- Versus Left-Sided Colon Cancer: A Propensity Score-Adjusted Analysis.
    Ann Surg Oncol. 2020 Sep 21. pii: 10.1245/s10434-020-09116.
    >> Share

  84. CREASY JM, Cunanan KM, Chakraborty J, McAuliffe JC, et al
    Differences in Liver Parenchyma are Measurable with CT Radiomics at Initial Colon Resection in Patients that Develop Hepatic Metastases from Stage II/III Colon Cancer.
    Ann Surg Oncol. 2020 Sep 20. pii: 10.1245/s10434-020-09134.
    >> Share

  85. LIN CC, Chen TH, Wu YC, Fang CY, et al
    Taiwan Society of Colon and Rectal Surgeons (TSCRS) Consensus for Cytoreduction Selection in Metastatic Colorectal Cancer.
    Ann Surg Oncol. 2020 Sep 1. pii: 10.1245/s10434-020-08914.
    >> Share

  86. KOBAYASHI S, Takahashi S, Takahashi N, Masuishi T, et al
    Survival Outcomes of Resected BRAF V600E Mutant Colorectal Liver Metastases: A Multicenter Retrospective Cohort Study in Japan.
    Ann Surg Oncol. 2020;27:3307-3315.
    >> Share

  87. KIM MJ, Chang GJ, Lim HK, Song MK, et al
    Oncological Impact of Lateral Lymph Node Dissection After Preoperative Chemoradiotherapy in Patients with Rectal Cancer.
    Ann Surg Oncol. 2020;27:3525-3533.
    >> Share

  88. VOOGT ELK, van Zoggel DMGI, Kusters M, Nieuwenhuijzen GAP, et al
    Improved Outcomes for Responders After Treatment with Induction Chemotherapy and Chemo(re)irradiation for Locally Recurrent Rectal Cancer.
    Ann Surg Oncol. 2020;27:3503-3513.
    >> Share

  89. YANG Y, Peacock O, Malakorn S, Limvorapitak T, et al
    Superior Mesenteric Vein-First Approach for Robotic Salvage Surgery with Indocyanine Green Fluorescence Angiography.
    Ann Surg Oncol. 2020;27:3500.
    >> Share

    August 2020
  90. FONG AJ, Lafaro K, Ituarte PHG, Fong Y, et al
    Association of Living in Urban Food Deserts with Mortality from Breast and Colorectal Cancer.
    Ann Surg Oncol. 2020 Aug 25. pii: 10.1245/s10434-020-09049.
    >> Share

  91. KIM HS, Kim NK
    ASO Author Reflections: Poorest Survival Outcomes in Patients with Right Colon Cancer with KRAS Mutation After Simultaneous Curative-Intent Surgery for Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2020 Aug 19. pii: 10.1245/s10434-020-09047.
    >> Share

  92. XIE H, Kim RD
    ASO Author Reflections: Clinical Utility of Circulating Tumor DNA Analysis in Colorectal Cancer: Current Status.
    Ann Surg Oncol. 2020 Aug 18. pii: 10.1245/s10434-020-09034.
    >> Share

  93. XIE H, Kim RD
    The Application of Circulating Tumor DNA in the Screening, Surveillance, and Treatment Monitoring of Colorectal Cancer.
    Ann Surg Oncol. 2020 Aug 9. pii: 10.1245/s10434-020-09002.
    >> Share

  94. NORO T
    ASO Author Reflections: Prognostic Impact of Budding Grade on Patients with Residual Liver Recurrence of Colorectal Cancer After Initial Hepatectomy.
    Ann Surg Oncol. 2020 Aug 7. pii: 10.1245/s10434-020-08792.
    >> Share

  95. ALLAIX ME, Rebecchi F, Fichera A
    ASO Author Reflections: Minimally Invasive Surgery for Colorectal Cancer: Where Do We Stand?
    Ann Surg Oncol. 2020 Aug 5. pii: 10.1245/s10434-020-08849.
    >> Share

  96. PEACOCK O, Chang GJ
    The Landmark Series: Management of Lateral Lymph Nodes in Locally Advanced Rectal Cancer.
    Ann Surg Oncol. 2020;27:2723-2731.
    >> Share

  97. STERPETTI AV, Costi U, Grande R, D'Ermo G, et al
    De Novo Secondary Adenocarcinoma in the Colon Used as Urinary Diversion Not in Contact with the Fecal Stream: Systematic Review and Meta-analysis.
    Ann Surg Oncol. 2020;27:2750-2759.
    >> Share

  98. KENNEDY ED, Pooni A
    Selection of Patients for Organ Preservation After Chemoradiotherapy: It Is Too Early to Exclude Any Method for Assessment of Response After CRT.
    Ann Surg Oncol. 2020;27:2580-2582.
    >> Share

  99. BROUQUET A, Benoist S
    ASO Author Reflections: Discordant Pathologic and Radiologic Response of Colorectal Liver Metastases After Chemotherapy: Which One Should We Trust to Predict Outcome and to Tailor Postoperative Chemotherapy?
    Ann Surg Oncol. 2020;27:2886-2887.
    >> Share

    July 2020
  100. SASO K, Miyoshi N, Fujino S, Sasaki M, et al
    Dipeptidyl Peptidase 9 Increases Chemoresistance and is an Indicator of Poor Prognosis in Colorectal Cancer.
    Ann Surg Oncol. 2020 Jul 30. pii: 10.1245/s10434-020-08729.
    >> Share

  101. ALLAIX ME, Rebecchi F, Fichera A
    The Landmark Series: Minimally Invasive (Laparoscopic and Robotic) Colorectal Cancer Surgery.
    Ann Surg Oncol. 2020 Jul 9. pii: 10.1245/s10434-020-08833.
    >> Share

  102. AKIYAMA T, Miyamoto Y, Imai K, Yamashita Y, et al
    Fibrosis-4 Index, a Noninvasive Fibrosis Marker, Predicts Survival Outcomes After Hepatectomy for Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2020 Jul 9. pii: 10.1245/s10434-020-08828.
    >> Share

  103. MAKAR GS, Makar M, Obinero C, Davis W, et al
    Refusal of Cancer-Directed Surgery in Patients with Colon Cancer: Risk Factors of Refusal and Survival Data.
    Ann Surg Oncol. 2020 Jul 7. pii: 10.1245/s10434-020-08783.
    >> Share

  104. SHERMAN SK, Chan CHF
    ASO Author Reflections: Mismatch Repair and Survival in Metastatic Colorectal Cancer.
    Ann Surg Oncol. 2020 Jul 6. pii: 10.1245/s10434-020-08803.
    >> Share

  105. CHOI AH, Senthil M
    ASO Author Reflections: Real-World Incidence of Peritoneal Carcinomatosis After Colon Cancer Resection and Why It Matters.
    Ann Surg Oncol. 2020 Jul 6. pii: 10.1245/s10434-020-08773.
    >> Share

  106. MAKAR GS, Davis W
    ASO Author Reflections: Which Patients with Colon Cancer Refuse Recommended Surgery?
    Ann Surg Oncol. 2020 Jul 1. pii: 10.1245/s10434-020-08798.
    >> Share

  107. MELNITCHOUK N, Fields AC, Lu P, Scully RE, et al
    Local versus Radical Excision of Early Distal Rectal Cancers: A National Cancer Database Analysis.
    Ann Surg Oncol. 2020;27:2169-2176.
    >> Share

  108. GIGLIO MC, Logghe B, Garofalo E, Tomassini F, et al
    Laparoscopic Versus Open Thermal Ablation of Colorectal Liver Metastases: A Propensity Score-Based Analysis of Local Control of the Ablated Tumors.
    Ann Surg Oncol. 2020;27:2370-2380.
    >> Share

  109. SMITH N, Waters PS, Peacock O, Kong JC, et al
    Pelvic Exenteration for Anal and Urogenital Squamous Cell Carcinoma: Experience and Outcomes from an Exenteration Unit Over 12 Years.
    Ann Surg Oncol. 2020;27:2450-2456.
    >> Share

  110. SPRINGER JE, Doumouras AG, Eskicioglu C, Hong D, et al
    Regional Variation in the Utilization of Laparoscopy for the Treatment of Rectal Cancer: The Importance of Fellowship Training Sites.
    Ann Surg Oncol. 2020;27:2478-2486.
    >> Share

    June 2020
  111. YOKOBORI T
    Editorial Comment on: DPP9 Increases Chemoresistance and is an Indicator of Poor Prognosis in Colorectal Cancer.
    Ann Surg Oncol. 2020 Jun 22. pii: 10.1245/s10434-020-08746.
    >> Share

  112. CHOI AH, Farzaneh C, Kejriwal N, Calidas A, et al
    Rate of Peritoneal Carcinomatosis in Resected Stage II and III Colon Cancer.
    Ann Surg Oncol. 2020 Jun 14. pii: 10.1245/s10434-020-08689.
    >> Share

  113. NORO T, Nishikawa M, Hoshikawa M, Einama T, et al
    Prognostic Impact of Budding Grade in Patients With Residual Liver Recurrence of Colorectal Cancer After Initial Hepatectomy.
    Ann Surg Oncol. 2020 Jun 2. pii: 10.1245/s10434-020-08684.
    >> Share


  114. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Colorectal Metastases.
    Ann Surg Oncol. 2020;27:1761-1767.
    >> Share

    May 2020
  115. KRATZ JD, LoConte NK
    Defining Early Multidisciplinary Goals: NEXTO Trial in High-Risk Colorectal Cancer with Liver Metastases.
    Ann Surg Oncol. 2020 May 22. pii: 10.1245/s10434-020-08629.
    >> Share

  116. BHATT A, Glehen O
    Extent of Peritoneal Resection for Peritoneal Metastases: Looking Beyond a Complete Cytoreduction.
    Ann Surg Oncol. 2020;27:1458-1470.
    >> Share

  117. BEKHOR E, Carr J, Hofstedt M, Sullivan B, et al
    The Safety of Iterative Cytoreductive Surgery and HIPEC for Peritoneal Carcinomatosis: A High Volume Center Prospectively Maintained Database Analysis.
    Ann Surg Oncol. 2020;27:1448-1455.
    >> Share

  118. MEROLA E, Rinke A, Partelli S, Gress TM, et al
    Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms?
    Ann Surg Oncol. 2020;27:1348-1355.
    >> Share

  119. HAYES IP, Milanzi E, Gibbs P, Reece JC, et al
    Neoadjuvant Chemoradiotherapy and Tumor Recurrence in Patients with Early T-Stage Cancer of the Lower Rectum.
    Ann Surg Oncol. 2020;27:1570-1579.
    >> Share

    April 2020
  120. SHINTO E, Yoshida Y, Kajiwara Y, Okamoto K, et al
    Clinical Significance of a Gene Signature Generated from Tumor Budding Grade in Colon Cancer.
    Ann Surg Oncol. 2020 Apr 23. pii: 10.1245/s10434-020-08498.
    >> Share

  121. PARK JH, Fuglestad AJ, Kostner AH, Oliwa A, et al
    Systemic Inflammation and Outcome in 2295 Patients with Stage I-III Colorectal Cancer from Scotland and Norway: First Results from the ScotScan Colorectal Cancer Group.
    Ann Surg Oncol. 2020 Apr 4. pii: 10.1245/s10434-020-08268.
    >> Share

  122. PAMEIJER CR
    Comment on "Diagnostic Laparoscopy as a Selection Tool for Patients with Colorectal Peritoneal Metastases to Prevent a Non-therapeutic Laparotomy During Cytoreductive Surgery".
    Ann Surg Oncol. 2020;27:975-977.
    >> Share

  123. ENGBERSEN MP, Aalbers AGJ, Van't Sant-Jansen I, Velsing JDR, et al
    Extent of Peritoneal Metastases on Preoperative DW-MRI is Predictive of Disease-Free and Overall Survival for CRS/HIPEC Candidates with Colorectal Cancer.
    Ann Surg Oncol. 2020 Apr 1. pii: 10.1245/s10434-020-08416.
    >> Share

  124. MACHADO MAC, Surjan RC, Makdissi F
    Robotic ALPPS.
    Ann Surg Oncol. 2020;27:1174-1179.
    >> Share

  125. ARRIZABALAGA NB, Navascues JME, Echaniz GE, Ansorena YS, et al
    Prophylactic HIPEC in pT4 Colon Tumors: Proactive Approach or Overtreatment?
    Ann Surg Oncol. 2020;27:1094-1100.
    >> Share

  126. HENTZEN JEKR, Constansia RDN, Been LB, Hoogwater FJH, et al
    Diagnostic Laparoscopy as a Selection Tool for Patients with Colorectal Peritoneal Metastases to Prevent a Non-therapeutic Laparotomy During Cytoreductive Surgery.
    Ann Surg Oncol. 2020;27:1084-1093.
    >> Share

    March 2020
  127. BEOM SH, Shin SJ, Kim CG, Kim JH, et al
    Clinical Significance of Preoperative Serum Carcinoembryonic Antigen Within the Normal Range in Colorectal Cancer Patients Undergoing Curative Resection.
    Ann Surg Oncol. 2020 Mar 16. pii: 10.1245/s10434-020-08256.
    >> Share

  128. MODEST DP, Heinemann V, Folprecht G, Denecke T, et al
    Factors That Influence Conversion to Resectability and Survival After Resection of Metastases in RAS WT Metastatic Colorectal Cancer (mCRC): Analysis of FIRE-3- AIOKRK0306.
    Ann Surg Oncol. 2020 Mar 14. pii: 10.1245/s10434-020-08219.
    >> Share

  129. VELD JV, Wisselink DD, Amelung FJ, Consten ECJ, et al
    Synchronous and Metachronous Peritoneal Metastases in Patients with Left-Sided Obstructive Colon Cancer.
    Ann Surg Oncol. 2020 Mar 13. pii: 10.1245/s10434-020-08327.
    >> Share

  130. FOLKERT IW, Roses RE
    ASO Author Reflections: Revisiting Risk of Dissemination from Small Rectal Neuroendocrine Tumors.
    Ann Surg Oncol. 2020;27:864-865.
    >> Share

  131. FOLKERT IW, Sinnamon AJ, Concors SJ, Bennett BJ, et al
    Grade is a Dominant Risk Factor for Metastasis in Patients with Rectal Neuroendocrine Tumors.
    Ann Surg Oncol. 2020;27:855-863.
    >> Share

    February 2020
  132. ZAFAR SN, Hu CY, Snyder RA, Cuddy A, et al
    Predicting Risk of Recurrence After Colorectal Cancer Surgery in the United States: An Analysis of a Special Commission on Cancer National Study.
    Ann Surg Oncol. 2020 Feb 20. pii: 10.1245/s10434-020-08238.
    >> Share

  133. IMAIZUMI K, Nishizawa Y, Ikeda K, Tsukada Y, et al
    Prognostic Impact of Curative Resection for Peritoneal Recurrence of Colorectal Cancer.
    Ann Surg Oncol. 2020 Feb 12. pii: 10.1245/s10434-020-08242.
    >> Share

  134. BOEDING JRE, Schreinemakers JMJ
    ASO Author Reflections: Patterns of Metastases in Patients with Obstructing Colorectal Cancer.
    Ann Surg Oncol. 2020 Feb 11. pii: 10.1245/s10434-020-08250.
    >> Share

  135. FRANZ C, Lang HM, Ghamarnejad O, Khajeh E, et al
    Prognostic Impact of Ventral Versus Dorsal Tumor Location After Total Mesorectal Excision of Rectal Cancer.
    Ann Surg Oncol. 2020;27:430-438.
    >> Share

  136. KREIS ME, Ruppert R, Kube R, Strassburg J, et al
    MRI-Based Use of Neoadjuvant Chemoradiotherapy in Rectal Carcinoma: Surgical Quality and Histopathological Outcome of the OCUM Trial.
    Ann Surg Oncol. 2020;27:417-427.
    >> Share

  137. FRANZ C, Kulu Y
    ASO Author Reflections: Tumor Location Affects Local Recurrence in Rectal Cancer.
    Ann Surg Oncol. 2020;27:439.
    >> Share

  138. JUNGINGER T
    ASO Author Reflections: From Overtreatment to Risk-Adjusted Therapy of Rectal Carcinoma.
    Ann Surg Oncol. 2020;27:428-429.
    >> Share

    January 2020
  139. CHARLTON M, Kahl A, Gao X, Schroeder M, et al
    Commentary and Complementary Data to Add to "Compliance with Cancer Quality Measures Over Time and Their Association with Survival Outcomes: The Commission on Cancer's Experience with the Quality Measure Requiring at Least 12 Regional Lymph Nodes to b
    Ann Surg Oncol. 2020 Jan 2. pii: 10.1245/s10434-019-08150.
    >> Share

  140. OSTERMAN E, Mezheyeuski A, Sjoblom T, Glimelius B, et al
    Beyond the NCCN Risk Factors in Colon Cancer: An Evaluation in a Swedish Population-Based Cohort.
    Ann Surg Oncol. 2020 Jan 1. pii: 10.1245/s10434-019-08148.
    >> Share

  141. BARATTI D, Kusamura S, Azmi N, Guaglio M, et al
    Colorectal Peritoneal Metastases Treated by Perioperative Systemic Chemotherapy and Cytoreductive Surgery With or Without Mitomycin C-Based HIPEC: A Comparative Study Using the Peritoneal Surface Disease Severity Score (PSDSS).
    Ann Surg Oncol. 2020;27:98-106.
    >> Share

  142. NARAYAN RR, Harris JW, Chou JF, Gonen M, et al
    Prediction of Recurrence Patterns from Hepatic Parenchymal Disease After Resection of Colorectal Liver Metastases.
    Ann Surg Oncol. 2020;27:188-195.
    >> Share

  143. ZAIDI MY, Lee RM, Gamboa AC, Speegle S, et al
    Preoperative Risk Score for Predicting Incomplete Cytoreduction: A 12-Institution Study from the US HIPEC Collaborative.
    Ann Surg Oncol. 2020;27:156-164.
    >> Share

  144. GRAF W, Cashin PH, Ghanipour L, Enblad M, et al
    Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC.
    Ann Surg Oncol. 2020;27:293-300.
    >> Share

  145. GAMBOA AC, Zaidi MY, Lee RM, Speegle S, et al
    Optimal Surveillance Frequency After CRS/HIPEC for Appendiceal and Colorectal Neoplasms: A Multi-institutional Analysis of the US HIPEC Collaborative.
    Ann Surg Oncol. 2020;27:134-146.
    >> Share

  146. ELLIS RJ, Schlick CJR, Yang AD, Barber EL, et al
    Utilization and Treatment Patterns of Cytoreduction Surgery and Intraperitoneal Chemotherapy in the United States.
    Ann Surg Oncol. 2020;27:214-221.
    >> Share

    December 2019
  147. OSTERMAN E, Glimelius B
    ASO Author Reflections: Emerging Risk Factors in Colon Cancer-End of the Line for Clinomics?
    Ann Surg Oncol. 2019 Dec 28. pii: 10.1245/s10434-019-08149.
    >> Share

  148. SHULMAN LN
    Dr Charlton et al., Commentary and Complementary Data to Add to "Compliance with Cancer Quality Measures Over Time and Their Association with Survival Outcomes: The Commission on Cancer's Experience with the Quality Measure Requiring at Least 12 Regio
    Ann Surg Oncol. 2019 Dec 19. pii: 10.1245/s10434-019-08152.
    >> Share

  149. KWAAN MR
    Postoperative CEA and Other Non-traditional Risk Factors for Colon Cancer Recurrence: Findings from Swedish Population-Based Data.
    Ann Surg Oncol. 2019 Dec 18. pii: 10.1245/s10434-019-08151.
    >> Share

  150. BOEDING JRE, Ramphal W, Crolla RMPH, Gobardhan PD, et al
    Differences in Metastatic Pattern in Patients Presenting With or Without Obstructing Colorectal Cancer: A Retrospective Observational Study of 2595 Patients.
    Ann Surg Oncol. 2019 Dec 10. pii: 10.1245/s10434-019-08119.
    >> Share

  151. BROUWER NPM, van der Kruijssen DEW, Hugen N, de Hingh IHJT, et al
    The Impact of Primary Tumor Location in Synchronous Metastatic Colorectal Cancer: Differences in Metastatic Sites and Survival.
    Ann Surg Oncol. 2019 Dec 2. pii: 10.1245/s10434-019-08100.
    >> Share

  152. KURBATOV V, Khan SA
    Exploring Microsatellite Instability (MSI) in Colorectal Cancer at Elevated Microsatellite Alterations at Selected Tetranucleotides (EMAST).
    Ann Surg Oncol. 2019 Dec 1. pii: 10.1245/s10434-019-08051.
    >> Share

    November 2019
  153. BROMAN KK, Parikh AA
    ASO Author Reflections: Location of Primary Colorectal Cancer and Risk of Second Primary Malignancy.
    Ann Surg Oncol. 2019 Nov 15. pii: 10.1245/s10434-019-07860.
    >> Share

  154. ITABASHI M, Yamamoto H, Tomita N, Inomata M, et al
    Lymph Node Positivity in One-Step Nucleic Acid Amplification is a Prognostic Factor for Postoperative Cancer Recurrence in Patients with Stage II Colorectal Cancer: A Prospective, Multicenter Study.
    Ann Surg Oncol. 2019 Nov 13. pii: 10.1245/s10434-019-07971.
    >> Share

  155. SUZUKI S, Akiyoshi T, Oba K, Otsuka F, et al
    Comprehensive Comparative Analysis of Prognostic Value of Systemic Inflammatory Biomarkers for Patients with Stage II/III Colon Cancer.
    Ann Surg Oncol. 2019 Nov 12. pii: 10.1245/s10434-019-07904.
    >> Share

  156. ZHANG Q, Peng J, Ye M, Weng W, et al
    KRAS Mutation Predicted More Mirometastases and Closer Resection Margins in Patients with Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2019 Nov 12. pii: 10.1245/s10434-019-08065.
    >> Share

  157. WEGNER RE, Abel S, Monga D, Raj M, et al
    Utilization of Adjuvant Radiotherapy for Resected Colon Cancer and Its Effect on Outcome.
    Ann Surg Oncol. 2019 Nov 12. pii: 10.1245/s10434-019-08042.
    >> Share

  158. SUZUKI S, Akiyoshi T
    ASO Author Reflections: Comparison of Prognostic Impact of Various Systemic Inflammatory Markers for Stage II/III Colon Cancer.
    Ann Surg Oncol. 2019 Nov 12. pii: 10.1245/s10434-019-08019.
    >> Share

  159. TURPIN A, Hebbar M
    ASO Author Reflections: Fong's Score in the Era of Modern Strategies for Metastatic Colorectal Cancer.
    Ann Surg Oncol. 2019 Nov 12. pii: 10.1245/s10434-019-08059.
    >> Share

  160. WATSON MM, Kanani A, Lea D, Khajavi RB, et al
    Elevated Microsatellite Alterations at Selected Tetranucleotides (EMAST) in Colorectal Cancer is Associated with an Elderly, Frail Phenotype and Improved Recurrence-Free Survival.
    Ann Surg Oncol. 2019 Nov 4. pii: 10.1245/s10434-019-08048.
    >> Share

    October 2019
  161. MARIANI A, Goere D
    ASO Author Reflections: What is the Best Therapeutic Strategy for Patients with Limited Synchronous Peritoneal Metastases of Colorectal Cancer?
    Ann Surg Oncol. 2019 Oct 30. pii: 10.1245/s10434-019-07829.
    >> Share

  162. MCSORLEY ST, Tham A, Dolan RD, Steele CW, et al
    Perioperative Blood Transfusion is Associated with Postoperative Systemic Inflammatory Response and Poorer Outcomes Following Surgery for Colorectal Cancer.
    Ann Surg Oncol. 2019 Oct 29. pii: 10.1245/s10434-019-07984.
    >> Share

  163. ARRAZUBI V
    ASO Author Reflections: Circulating Tumor Cell Count is a Prognostic Factor in Patients with Resected Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2019 Oct 28. pii: 10.1245/s10434-019-08005.
    >> Share

  164. MAKHLOUFI S, Turpin A, El Amrani M, Andre T, et al
    Fong's Score in the Era of Modern Perioperative Chemotherapy for Metastatic Colorectal Cancer: A Post Hoc Analysis of the GERCOR-MIROX Phase III Trial.
    Ann Surg Oncol. 2019 Oct 22. pii: 10.1245/s10434-019-07976.
    >> Share

  165. VAN WYK HC, Roseweir A, Alexander P, Park JH, et al
    The Relationship Between Tumor Budding, Tumor Microenvironment, and Survival in Patients with Primary Operable Colorectal Cancer.
    Ann Surg Oncol. 2019 Oct 11. pii: 10.1245/s10434-019-07931.
    >> Share

  166. KOTHA NV, Kelly KJ
    ASO Author Reflections: Clinical Significance of Primary Tumor Side in Peritoneal Metastatic Colon Cancer.
    Ann Surg Oncol. 2019 Oct 10. pii: 10.1245/s10434-019-07916.
    >> Share

  167. WANG YY, Liu ZZ, Xu D, Liu M, et al
    Fibrinogen-Albumin Ratio Index (FARI): A More Promising Inflammation-Based Prognostic Marker for Patients Undergoing Hepatectomy for Colorectal Liver Metastases.
    Ann Surg Oncol. 2019;26:3682-3692.
    >> Share

  168. RIBI K, Marti WR, Bernhard J, Grieder F, et al
    Quality of Life After Total Mesorectal Excision and Rectal Replacement: Comparing Side-to-End, Colon J-Pouch and Straight Colorectal Reconstruction in a Randomized, Phase III Trial (SAKK 40/04).
    Ann Surg Oncol. 2019;26:3568-3576.
    >> Share

  169. JEDDOU H, Tzedakis S, Sulpice L, Boudjema K, et al
    Resection of the Dorsal Sector of the Liver: The Anterior Transhepatic Approach.
    Ann Surg Oncol. 2019;26:3681.
    >> Share

    September 2019
  170. YOKOTA K, Tanaka Y, Harada H, Kaida T, et al
    WiNTRLINC1/ASCL2/c-Myc Axis Characteristics of Colon Cancer with Differentiated Histology at Young Onset and Essential for Cell Viability.
    Ann Surg Oncol. 2019 Sep 23. pii: 10.1245/s10434-019-07780.
    >> Share

  171. IWAMOTO K, Takahashi H, Fujii M, Haraguchi N, et al
    Correction to: Safety of Single-Site Laparoscopic Surgery Requiring Perioperative Heparinization in Colorectal Cancer: Propensity Score-Matched Analysis.
    Ann Surg Oncol. 2019 Sep 17. pii: 10.1245/s10434-019-07839.
    >> Share

  172. IWAMOTO K, Takahashi H, Fujii M, Haraguchi N, et al
    Safety of Single-Site Laparoscopic Surgery Requiring Perioperative Heparinization in Colorectal Cancer: Propensity Score-Matched Analysis.
    Ann Surg Oncol. 2019 Sep 6. pii: 10.1245/s10434-019-07794.
    >> Share

  173. KARAGKOUNIS G, Liska D
    Bridging the Gap: Making Sense of the Diverging Evidence for Self-Expandable Metallic Stents in Malignant Colonic Obstructions.
    Ann Surg Oncol. 2019;26:2657-2659.
    >> Share

  174. STROMBOM P, Widmar M, Keskin M, Gennarelli RL, et al
    Assessment of the Value of Comorbidity Indices for Risk Adjustment in Colorectal Surgery Patients.
    Ann Surg Oncol. 2019;26:2797-2804.
    >> Share

  175. HOPPENER DJ, Nierop PMH, van Amerongen MJ, Olthof PB, et al
    The Disease-Free Interval Between Resection of Primary Colorectal Malignancy and the Detection of Hepatic Metastases Predicts Disease Recurrence But Not Overall Survival.
    Ann Surg Oncol. 2019;26:2812-2820.
    >> Share

  176. YANG SY, Park YY, Han YD, Cho MS, et al
    Oncologic Outcomes of Self-Expandable Metallic Stent as a Bridge to Surgery and Safety and Feasibility of Minimally Invasive Surgery for Acute Malignant Colonic Obstruction.
    Ann Surg Oncol. 2019;26:2787-2796.
    >> Share

    August 2019
  177. SHINDOH J, Kobayashi Y, Kinowaki K, Mise Y, et al
    Dynamic Changes in Normal Liver Parenchymal Volume During Chemotherapy for Colorectal Cancer: Liver Atrophy as an Alternate Marker of Chemotherapy-Associated Liver Injury.
    Ann Surg Oncol. 2019 Aug 22. pii: 10.1245/s10434-019-07740.
    >> Share

  178. YOSHIDA T, Shida D
    ASO Author Reflections: Partial versus Total Cystectomy in Bladder-Involving Colorectal Cancer.
    Ann Surg Oncol. 2019 Aug 9. pii: 10.1245/s10434-019-07716.
    >> Share

  179. ARJONA-SANCHEZ A, Rodriguez-Ortiz L, Baratti D, Schneider MA, et al
    RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy of Colorectal Peritoneal Metastasis: A Modification Proposal of the Peritoneal Surface Disease Severity Score.
    Ann Surg Oncol. 2019;26:2595-2604.
    >> Share

  180. YANG Y, Malakorn S, Maldonado K, Bednarski BK, et al
    The Pelvis-First Approach for Robotic Proctectomy in Patients with Redundant Abdominal Colon.
    Ann Surg Oncol. 2019;26:2514-2515.
    >> Share

  181. HALVERSON AL, Morris AM, Cleary RK, Chang GJ, et al
    For Patients with Early Rectal Cancer, Does Local Excision Have an Impact on Recurrence, Survival, and Quality of Life Relative to Radical Resection?
    Ann Surg Oncol. 2019;26:2497-2506.
    >> Share

  182. ARJONA-SANCHEZ A, Rodriguez-Ortiz L
    ASO Author Reflections: Tending Towards a Personalized Medicine for Colorectal Carcinomatosis by Adding the RAS Mutation Status in the Workup for CRS and HIPEC.
    Ann Surg Oncol. 2019;26:2605-2606.
    >> Share

  183. KONISHI T, Shinozaki E, Murofushi K, Taguchi S, et al
    Phase II Trial of Neoadjuvant Chemotherapy, Chemoradiotherapy, and Laparoscopic Surgery with Selective Lateral Node Dissection for Poor-Risk Low Rectal Cancer.
    Ann Surg Oncol. 2019;26:2507-2513.
    >> Share

  184. MATSUDA T, Hasegawa H, Yamashita K, Takase N, et al
    Laparoscopic Complete Mesocolic Excision for Double Flexural Colon Cancers.
    Ann Surg Oncol. 2019;26:2516.
    >> Share

    July 2019
  185. SHIDA D
    ASO Author Reflections: Prognostic Impact of Primary Tumor Sidedness for Unresectable Stage IV Colorectal Cancer.
    Ann Surg Oncol. 2019 Jul 29. pii: 10.1245/s10434-019-07666.
    >> Share

  186. YOMODA T
    ASO Author Reflections: Analysis of PD-L1 Expression and Immunoscore in Colorectal Cancer.
    Ann Surg Oncol. 2019 Jul 22. pii: 10.1245/s10434-019-07363.
    >> Share

  187. ROXBURGH CSD, Strombom P, Lynn P, Gonen M, et al
    Role of the Interval from Completion of Neoadjuvant Therapy to Surgery in Postoperative Morbidity in Patients with Locally Advanced Rectal Cancer.
    Ann Surg Oncol. 2019;26:2019-2027.
    >> Share

  188. FERNANDEZ LM, Perez RO
    Longer Intervals from Neoadjuvant Therapy to Rectal Cancer Surgery: The Clock is Ticking....
    Ann Surg Oncol. 2019;26:1957-1958.
    >> Share

  189. FIELDS AC, McCarty JC, Lu P, Vierra BM, et al
    Colon Neuroendocrine Tumors: A New Lymph Node Staging Classification.
    Ann Surg Oncol. 2019;26:2028-2036.
    >> Share

  190. HENTZEN JEKR, Rovers KP, Kuipers H, van der Plas WY, et al
    Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study.
    Ann Surg Oncol. 2019;26:2210-2221.
    >> Share

    June 2019
  191. LAZARUS J, Oneka MD, Barua S, Maj T, et al
    Mathematical Modeling of the Metastatic Colorectal Cancer Microenvironment Defines the Importance of Cytotoxic Lymphocyte Infiltration and Presence of PD-L1 on Antigen Presenting Cells.
    Ann Surg Oncol. 2019 Jun 27. pii: 10.1245/s10434-019-07508.
    >> Share

  192. ARRAZUBI V, Mata E, Antelo ML, Tarifa A, et al
    Circulating Tumor Cells in Patients Undergoing Resection of Colorectal Cancer Liver Metastases. Clinical Utility for Long-Term Outcome: A Prospective Trial.
    Ann Surg Oncol. 2019 Jun 17. pii: 10.1245/s10434-019-07503.
    >> Share

  193. BRUZZI M, Auclin E, Lo Dico R, Voron T, et al
    Influence of Molecular Status on Recurrence Site in Patients Treated for a Stage III Colon Cancer: a Post Hoc Analysis of the PETACC-8 Trial.
    Ann Surg Oncol. 2019 Jun 17. pii: 10.1245/s10434-019-07513.
    >> Share

  194. TANAKA T, Yamashita K
    ASO Author Reflections: ASCL2, a Marker of Dynamic Colon Stem Cell, Involved in Wnt Pathway Activation Reflects Anti-cancer Drug Resistance in Primary Colorectal Cancer.
    Ann Surg Oncol. 2019 Jun 13. pii: 10.1245/s10434-019-07469.
    >> Share

  195. ZHOU X, Yi Y, Liu Z, Cao W, et al
    Radiomics-Based Pretherapeutic Prediction of Non-response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
    Ann Surg Oncol. 2019;26:1676-1684.
    >> Share

    May 2019
  196. CHOUDRY HA, Bednar F, Shuai Y, Jones HL, et al
    Repeat Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemoperfusion is Feasible and Offers Survival Benefit in Select Patients with Peritoneal Metastases.
    Ann Surg Oncol. 2019;26:1445-1453.
    >> Share

  197. MARIANI A, Gelli M, Sourrouille I, Benhaim L, et al
    Strategies for Managing Intraoperative Discovery of Limited Colorectal Peritoneal Metastases.
    Ann Surg Oncol. 2019;26:1437-1444.
    >> Share

  198. LEWIS GD, Haque W, Butler EB, Teh BS, et al
    Survival Outcomes and Patterns of Management for Anal Adenocarcinoma.
    Ann Surg Oncol. 2019;26:1351-1357.
    >> Share

    April 2019
  199. PEREYRA D, Starlinger P
    ASO Author Reflections: APRI + ALBI: A Novel Tool for Estimating Chemotherapy-Associated Liver Injury in Patients with Colorectal Cancer Liver Metastasis Undergoing Liver Resection.
    Ann Surg Oncol. 2019 Apr 29. pii: 10.1245/s10434-019-07395.
    >> Share

  200. KOTHA NV, Baumgartner JM, Veerapong J, Cloyd JM, et al
    Primary Tumor Sidedness is Predictive of Survival in Colon Cancer Patients Treated with Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A US HIPEC Collaborative Study.
    Ann Surg Oncol. 2019 Apr 23. pii: 10.1245/s10434-019-07373.
    >> Share

  201. BROMAN KK, Bailey CE, Parikh AA
    Sidedness of Colorectal Cancer Impacts Risk of Second Primary Gastrointestinal Malignancy.
    Ann Surg Oncol. 2019 Apr 4. pii: 10.1245/s10434-019-07326.
    >> Share

  202. BERGER Y, Jacoby H, Kaufmann MI, Ben-Yaacov A, et al
    Correlation Between Intraoperative and Pathological Findings for Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Ann Surg Oncol. 2019;26:1103-1109.
    >> Share

  203. HAGEMANS JAW, Rothbarth J, van Bogerijen GHW, van Meerten E, et al
    Treatment of Inguinal Lymph Node Metastases in Patients with Rectal Adenocarcinoma.
    Ann Surg Oncol. 2019;26:1134-1141.
    >> Share

  204. FIELDS AC, Lu P, Vierra BM, Hu F, et al
    Survival in Patients with High-Grade Colorectal Neuroendocrine Carcinomas: The Role of Surgery and Chemotherapy.
    Ann Surg Oncol. 2019;26:1127-1133.
    >> Share

    March 2019
  205. SHULMAN LN, Browner AE, Palis BE, Mallin K, et al
    Compliance with Cancer Quality Measures Over Time and Their Association with Survival Outcomes: The Commission on Cancer's Experience with the Quality Measure Requiring at Least 12 Regional Lymph Nodes to be Removed and Analyzed with Colon Cancer Rese
    Ann Surg Oncol. 2019 Mar 29. pii: 10.1245/s10434-019-07323.
    >> Share

  206. HUANG SH, Tsai WS, You JF, Hung HY, et al
    Preoperative Carcinoembryonic Antigen as a Poor Prognostic Factor in Stage I-III Colorectal Cancer After Curative-Intent Resection: A Propensity Score Matching Analysis.
    Ann Surg Oncol. 2019 Mar 26. pii: 10.1245/s10434-019-07184.
    >> Share

  207. KAMATH SD, Khorana AA
    Does Sidedness Matter in Unresectable Colorectal Cancer?
    Ann Surg Oncol. 2019 Mar 18. pii: 10.1245/s10434-019-07315.
    >> Share

  208. YOSHIDA T, Shida D, Taniguchi H, Tsukamoto S, et al
    Long-Term Outcomes Following Partial Versus Complete Cystectomy in Advanced Colorectal Cancer with Regarding to the Extent of Bladder Invasion.
    Ann Surg Oncol. 2019 Mar 7. pii: 10.1245/s10434-019-07276.
    >> Share

  209. VELD JV, Amelung FJ, van Hooft JE, Tanis PJ, et al
    Letter to the Editor Regarding 'What is the Best Option Between Primary Diverting Stoma or Endoscopic Stent as a Bridge to Surgery with a Curative Intent for Obstructed Left Colon Cancer? Results from a Propensity Score Analysis of the French Surgical
    Ann Surg Oncol. 2019 Mar 7. pii: 10.1245/s10434-019-07279.
    >> Share

  210. MEGE D, Sabbagh C, Manceau G, Karoui M, et al
    Response to Dr. Veld et al. Regarding the Manuscript Titled "What is the Best Option Between Primary Diverting Stoma or Endoscopic Stent as a Bridge to Surgery with a Curative Intent for Obstructed Left Colon Cancer? Results from a Propensity Score An
    Ann Surg Oncol. 2019 Mar 6. pii: 10.1245/s10434-019-07281.
    >> Share

  211. SOTIRCHOS VS, Fujisawa S, Vakiani E, Solomon SB, et al
    Fluorescent Tissue Assessment of Colorectal Cancer Liver Metastases Ablation Zone: A Potential Real-Time Biomarker of Complete Tumor Ablation.
    Ann Surg Oncol. 2019 Mar 4. pii: 10.1245/s10434-018-07133.
    >> Share

  212. PEREYRA D, Rumpf B, Ammann M, Perrodin SF, et al
    The Combination of APRI and ALBI Facilitates Preoperative Risk Stratification for Patients Undergoing Liver Surgery After Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2019;26:791-799.
    >> Share

  213. VAN HOUDT WJ, Wei IH, Kuk D, Qin LX, et al
    Yield of Colonoscopy in Identification of Newly Diagnosed Desmoid-Type Fibromatosis with Underlying Familial Adenomatous Polyposis.
    Ann Surg Oncol. 2019;26:765-771.
    >> Share

  214. SUN W, Dou R, Chen J, Lai S, et al
    Impact of Long-Course Neoadjuvant Radiation on Postoperative Low Anterior Resection Syndrome and Quality of Life in Rectal Cancer: Post Hoc Analysis of a Randomized Controlled Trial.
    Ann Surg Oncol. 2019;26:746-755.
    >> Share

    February 2019
  215. KELLY KJ, Alsayadnasser M, Vaida F, Veerapong J, et al
    Does Primary Tumor Side Matter in Patients with Metastatic Colon Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy?
    Ann Surg Oncol. 2019 Feb 27. pii: 10.1245/s10434-019-07255.
    >> Share

  216. HA GW, Kim JH, Lee MR
    Oncologic Effects of Primary Tumor-Sidedness on Patients with Stages 1-3 Colon Cancer: A Meta-Analysis.
    Ann Surg Oncol. 2019 Feb 25. pii: 10.1245/s10434-019-07164.
    >> Share

  217. SPINOGLIO G, Bianchi PP, Marano A, Priora F, et al
    Correction to: Robotic Versus Laparoscopic Right Colectomy with Complete Mesocolic Excision for the Treatment of Colon Cancer: Perioperative Outcomes and 5-Year Survival in a Consecutive Series of 202 Patients.
    Ann Surg Oncol. 2019 Feb 25. pii: 10.1245/s10434-019-07267.
    >> Share

  218. SHIDA D, Tanabe T, Boku N, Takashima A, et al
    Prognostic Value of Primary Tumor Sidedness for Unresectable Stage IV Colorectal Cancer: A Retrospective Study.
    Ann Surg Oncol. 2019 Feb 4. pii: 10.1245/s10434-019-07209.
    >> Share

  219. FEFERMAN Y, Solomon D, Bhagwandin S, Kim J, et al
    Sites of Recurrence After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis from Colorectal and Appendiceal Adenocarcinoma: A Tertiary Center Experience.
    Ann Surg Oncol. 2019;26:482-489.
    >> Share

  220. DETERING R, Borstlap WAA, Broeders L, Hermus L, et al
    Cross-Sectional Study on MRI Restaging After Chemoradiotherapy and Interval to Surgery in Rectal Cancer: Influence on Short- and Long-Term Outcomes.
    Ann Surg Oncol. 2019;26:437-448.
    >> Share

  221. PALTER VN, Baker NA, Pollett A, Daly C, et al
    Learning by Example: An International Perspective on Reflex-Testing for Lynch Syndrome.
    Ann Surg Oncol. 2019;26:425-436.
    >> Share

    January 2019
  222. NARAYAN RR, Goldman DA, Gonen M, Reichel J, et al
    Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer.
    Ann Surg Oncol. 2019 Jan 31. pii: 10.1245/s10434-019-07201.
    >> Share

  223. TANAKA T, Kojima K, Yokota K, Tanaka Y, et al
    Comprehensive Genetic Search to Clarify the Molecular Mechanism of Drug Resistance Identifies ASCL2-LEF1/TSPAN8 Axis in Colorectal Cancer.
    Ann Surg Oncol. 2019 Jan 31. pii: 10.1245/s10434-019-07172.
    >> Share

  224. YOMODA T, Sudo T, Kawahara A, Shigaki T, et al
    Correction to: The Immunoscore is a Superior Prognostic Tool in Stages II and III Colorectal Cancer and is Significantly Correlated with Programmed Death-Ligand 1 (PD-L1) Expression on Tumor-Infiltrating Mononuclear Cells.
    Ann Surg Oncol. 2019 Jan 29. pii: 10.1245/s10434-019-07208.
    >> Share

  225. HAMILTON TD, MacNeill AJ, Lim H, Hunink MGM, et al
    Cost-Effectiveness Analysis of Cytoreductive Surgery and HIPEC Compared With Systemic Chemotherapy in Isolated Peritoneal Carcinomatosis From Metastatic Colorectal Cancer.
    Ann Surg Oncol. 2019 Jan 28. pii: 10.1245/s10434-018-07111.
    >> Share

  226. LEE SY, Kim DW, Kang SI, Ihn MH, et al
    Impact of Family History on Prognosis of Patients with Sporadic Colorectal Cancer.
    Ann Surg Oncol. 2019 Jan 25. pii: 10.1245/s10434-019-07179.
    >> Share

  227. JACOBSON R, Sherman SK, Dahdaleh F, Turaga KK, et al
    Correction to: Peritoneal Metastases in Colorectal Cancer.
    Ann Surg Oncol. 2019 Jan 16. pii: 10.1245/s10434-019-07173.
    >> Share

  228. SOLOMON D, DeNicola NL, Feferman Y, Bekhor E, et al
    More Synchronous Peritoneal Disease but Longer Survival in Younger Patients with Carcinomatosis from Colorectal Cancer Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Ann Surg Oncol. 2019 Jan 14. pii: 10.1245/s10434-018-07087.
    >> Share

  229. MEGE D, Sabbagh C, Manceau G, Bridoux V, et al
    What is the Best Option Between Primary Diverting Stoma or Endoscopic Stent as a Bridge to Surgery with a Curative Intent for Obstructed Left Colon Cancer? Results from a Propensity Score Analysis of the French Surgical Association Multicenter Cohort
    Ann Surg Oncol. 2019 Jan 8. pii: 10.1245/s10434-018-07139.
    >> Share

  230. SLUITER NR, Tuynman JB
    ASO Author Reflections: Advanced Imaging Allows Better Detection of Peritoneal Metastases.
    Ann Surg Oncol. 2019;26:165-166.
    >> Share

  231. SLUITER NR, Vlek SL, Wijsmuller AR, Brandsma HT, et al
    Narrow-Band Imaging Improves Detection of Colorectal Peritoneal Metastases: A Clinical Study Comparing Advanced Imaging Techniques.
    Ann Surg Oncol. 2019;26:156-164.
    >> Share

  232. MACHADO MA, Surjan RC, Basseres T, Makdissi F, et al
    Robotic Repeat Right Hepatectomy for Recurrent Colorectal Liver Metastasis.
    Ann Surg Oncol. 2019;26:292-295.
    >> Share

  233. LEE AJ, Loyer EM, Kang HC, Aloia TA, et al
    Intrahepatic Recurrence Patterns Predict Survival After Resection of Colorectal Liver Metastases.
    Ann Surg Oncol. 2019;26:275-281.
    >> Share

  234. DUCHALAIS E, Larson DW, Machairas N, Mathis KL, et al
    Outcomes of Early Removal of Urinary Catheter Following Rectal Resection for Cancer.
    Ann Surg Oncol. 2019;26:79-85.
    >> Share

    December 2018
  235. YOMODA T, Sudo T, Kawahara A, Shigaki T, et al
    The Immunoscore is a Superior Prognostic Tool in Stages II and III Colorectal Cancer and is Significantly Correlated with Programmed Death-Ligand 1 (PD-L1) Expression on Tumor-Infiltrating Mononuclear Cells.
    Ann Surg Oncol. 2018 Dec 19. pii: 10.1245/s10434-018-07110.
    >> Share

  236. FLAHERTY DC, Bilchik AJ
    ASO Author Reflections: Can the Association Between Obesity and Colorectal Cancer Be Explained by an Unfavorable Tumor Immune Microenvironment?
    Ann Surg Oncol. 2018 Dec 6. pii: 10.1245/s10434-018-7011.
    >> Share

  237. CHOUDRY MHA, Shuai Y, Jones HL, Pai RK, et al
    Postoperative Complications Independently Predict Cancer-Related Survival in Peritoneal Malignancies.
    Ann Surg Oncol. 2018;25:3950-3959.
    >> Share

  238. KIM WR, Han YD, Min BS
    C-Reactive Protein Level Predicts Survival Outcomes in Rectal Cancer Patients Undergoing Total Mesorectal Excision After Preoperative Chemoradiation Therapy.
    Ann Surg Oncol. 2018;25:3898-3905.
    >> Share

    November 2018
  239. OSHI M, Margonis GA, Sawada Y, Andreatos N, et al
    Higher Tumor Burden Neutralizes Negative Margin Status in Hepatectomy for Colorectal Cancer Liver Metastasis.
    Ann Surg Oncol. 2018 Nov 27. pii: 10.1245/s10434-018-6830.
    >> Share

  240. PASSOT G, Vauthey JN, Chun YS
    ASO Author Reflections: RAS Mutations in Metastatic Colorectal Cancer.
    Ann Surg Oncol. 2018 Nov 12. pii: 10.1245/s10434-018-7020.
    >> Share

  241. CLEARY RK, Morris AM, Chang GJ, Halverson AL, et al
    Controversies in Surgical Oncology: Does the Minimally Invasive Approach for Rectal Cancer Provide Equivalent Oncologic Outcomes Compared with the Open Approach?
    Ann Surg Oncol. 2018;25:3587-3595.
    >> Share

  242. ROUANET P, Bertrand MM, Jarlier M, Mourregot A, et al
    Robotic Versus Laparoscopic Total Mesorectal Excision for Sphincter-Saving Surgery: Results of a Single-Center Series of 400 Consecutive Patients and Perspectives.
    Ann Surg Oncol. 2018;25:3572-3579.
    >> Share

    October 2018
  243. SOUWER ETD, Hultink D, Bastiaannet E, Hamaker ME, et al
    The Prognostic Value of a Geriatric Risk Score for Older Patients with Colorectal Cancer.
    Ann Surg Oncol. 2018 Oct 25. pii: 10.1245/s10434-018-6867.
    >> Share

  244. CREASY JM, D'Angelica MI
    ASO Author Reflections: Primary Tumor Location and Long-Term Survival After Hepatic Resection for Metastatic Colon Cancer.
    Ann Surg Oncol. 2018 Oct 17. pii: 10.1245/s10434-018-6918.
    >> Share

  245. YOKOI K, Harada H, Yokota K, Ishii S, et al
    Epigenetic Status of CDO1 Gene May Reflect Chemosensitivity in Colon Cancer with Postoperative Adjuvant Chemotherapy.
    Ann Surg Oncol. 2018 Oct 11. pii: 10.1245/s10434-018-6865.
    >> Share

  246. PINAR I, Fransgaard T, Thygesen LC, Gogenur I, et al
    Long-Term Outcomes of Robot-Assisted Surgery in Patients with Colorectal Cancer.
    Ann Surg Oncol. 2018 Oct 11. pii: 10.1245/s10434-018-6862.
    >> Share

  247. SHINTO E, Hida JI, Ike H, Kobayashi H, et al
    A New N Staging System for Colorectal Cancer in the Era of Extended Lymphadenectomy.
    Ann Surg Oncol. 2018 Oct 1. pii: 10.1245/s10434-018-6786.
    >> Share

  248. ACUNA SA, Chesney TR, Amarasekera ST, Baxter NN, et al
    Defining Non-inferiority Margins for Quality of Surgical Resection for Rectal Cancer: A Delphi Consensus Study.
    Ann Surg Oncol. 2018;25:3171-3178.
    >> Share

    September 2018
  249. WEERINK LBM, Gant CM, van Leeuwen BL, de Bock GH, et al
    Long-Term Survival in Octogenarians After Surgical Treatment for Colorectal Cancer: Prevention of Postoperative Complications is Key.
    Ann Surg Oncol. 2018 Sep 22. pii: 10.1245/s10434-018-6766.
    >> Share

  250. SPINOGLIO G, Bianchi PP, Marano A, Priora F, et al
    Robotic Versus Laparoscopic Right Colectomy with Complete Mesocolic Excision for the Treatment of Colon Cancer: Perioperative Outcomes and 5-Year Survival in a Consecutive Series of 202 Patients.
    Ann Surg Oncol. 2018 Sep 14. pii: 10.1245/s10434-018-6752.
    >> Share

  251. FIELDS AC, Goldberg J, Senturk J, Saadat LV, et al
    Contemporary Surgical Management and Outcomes for Anal Melanoma: A National Cancer Database Analysis.
    Ann Surg Oncol. 2018 Sep 12. pii: 10.1245/s10434-018-6769.
    >> Share

  252. ANGKA L, Martel AB, Kilgour M, Jeong A, et al
    Natural Killer Cell IFNgamma Secretion is Profoundly Suppressed Following Colorectal Cancer Surgery.
    Ann Surg Oncol. 2018 Sep 5. pii: 10.1245/s10434-018-6691.
    >> Share

  253. ASARE EA, Vreeland TJ, Feig BW
    Resection of a Perirectal Leiomyosarcoma via a Posterior Transcoccygeal Approach.
    Ann Surg Oncol. 2018;25:2641.
    >> Share

    August 2018
  254. MIRKIN KA, Kulaylat AS, Hollenbeak CS, Messaris E, et al
    Prognostic Significance of Tumor Deposits in Stage III Colon Cancer.
    Ann Surg Oncol. 2018 Aug 6. pii: 10.1245/s10434-018-6661.
    >> Share

  255. LEE ZJ, Chia SL, Tan G, Soo KC, et al
    Cost Effectiveness of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Management of Colorectal Peritoneal Carcinomatosis.
    Ann Surg Oncol. 2018;25:2340-2346.
    >> Share

  256. SLUITER NR, Rovers KP, Salhi Y, Vlek SL, et al
    Metachronous Peritoneal Metastases After Adjuvant Chemotherapy are Associated with Poor Outcome After Cytoreduction and HIPEC.
    Ann Surg Oncol. 2018;25:2347-2356.
    >> Share

  257. BECERRA AZ, Wexner SD, Dietz DW, Xu Z, et al
    Nationwide Heterogeneity in Hospital-Specific Probabilities of Rectal Cancer Understaging and Its Effects on Outcomes.
    Ann Surg Oncol. 2018;25:2332-2339.
    >> Share

    July 2018
  258. LEE DW, Han SW, Kang JK, Bae JM, et al
    Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer.
    Ann Surg Oncol. 2018 Jul 30. pii: 10.1245/s10434-018-6681.
    >> Share

  259. MARTIN L, Hopkins J, Malietzis G, Jenkins JT, et al
    Assessment of Computed Tomography (CT)-Defined Muscle and Adipose Tissue Features in Relation to Short-Term Outcomes After Elective Surgery for Colorectal Cancer: A Multicenter Approach.
    Ann Surg Oncol. 2018 Jul 13. pii: 10.1245/s10434-018-6652.
    >> Share

  260. HAGEMANS JAW, Blinde SE, Nuyttens JJ, Morshuis WG, et al
    Salvage Abdominoperineal Resection for Squamous Cell Anal Cancer: A 30-Year Single-Institution Experience.
    Ann Surg Oncol. 2018;25:1970-1979.
    >> Share

  261. VAN EDEN WJ, Elekonawo FMK, Starremans BJ, Kok NFM, et al
    Treatment of Isolated Peritoneal Recurrences in Patients with Colorectal Peritoneal Metastases Previously Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Ann Surg Oncol. 2018;25:1992-2001.
    >> Share

    June 2018
  262. HAMABE A, Park S, Morita S, Tanida T, et al
    Analysis of the Vascular Interrelationships Among the First Jejunal Vein, the Superior Mesenteric Artery, and the Middle Colic Artery.
    Ann Surg Oncol. 2018;25:1661-1667.
    >> Share

  263. FIORENTINI G, Ratti F, Cipriani F, Catena M, et al
    Tips and Tricks for a Laparoscopic Approach to Paracaval Liver Segments.
    Ann Surg Oncol. 2018;25:1695-1698.
    >> Share

  264. GOFFREDO P, Garancini M, Robinson TJ, Frakes J, et al
    A National-Level Validation of the New American Joint Committee on Cancer 8th Edition Subclassification of Stage IIA and B Anal Squamous Cell Cancer.
    Ann Surg Oncol. 2018;25:1654-1660.
    >> Share

  265. VIGANO L, Darwish SS, Rimassa L, Cimino M, et al
    Progression of Colorectal Liver Metastases from the End of Chemotherapy to Resection: A New Contraindication to Surgery?
    Ann Surg Oncol. 2018;25:1676-1685.
    >> Share

    May 2018
  266. OKUNO M, Goumard C, Kopetz S, Vega EA, et al
    RAS Mutation is Associated with Unsalvageable Recurrence Following Hepatectomy for Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2018 May 21. pii: 10.1245/s10434-018-6517.
    >> Share

  267. NARAYANAN S, Kawaguchi T, Yan L, Peng X, et al
    Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer.
    Ann Surg Oncol. 2018 May 16. pii: 10.1245/s10434-018-6506.
    >> Share

  268. VAN DEN BROEK J, Geenen R, Heijnen L, Kobus C, et al
    Adrenal Incidentalomas During Diagnostic Work-up of Colorectal Cancer Patients: What is the Risk of Metastases?
    Ann Surg Oncol. 2018 May 14. pii: 10.1245/s10434-018-6501.
    >> Share

  269. JACOBSON R, Sherman SK, Dadaleh F, Turaga KK, et al
    Peritoneal Metastases in Colorectal Cancer.
    Ann Surg Oncol. 2018 May 10. pii: 10.1245/s10434-018-6490.
    >> Share

  270. SPASOJEVIC M, Mariathasan AB, Goscinski M, Thorgersen EB, et al
    Vertical Rectus Abdominis Musculocutaneous Flap Repair Improves Perineal Wound Healing after Abdominoperineal Resection for Irradiated Locally Advanced Rectal Cancer.
    Ann Surg Oncol. 2018;25:1357-1365.
    >> Share

  271. WASIF N, Etzioni D, Habermann EB, Mathur A, et al
    Racial and Socioeconomic Differences in the Use of High-Volume Commission on Cancer-Accredited Hospitals for Cancer Surgery in the United States.
    Ann Surg Oncol. 2018;25:1116-1125.
    >> Share

    April 2018
  272. PARK JS, Ng KS, Saw RPM, Thompson JF, et al
    Metastatic Melanoma to the Colon, Rectum, and Anus: A 50-Year Experience.
    Ann Surg Oncol. 2018 Apr 24. pii: 10.1245/s10434-018-6451.
    >> Share

  273. BABCOCK BD, Aljehani MA, Jabo B, Choi AH, et al
    High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal.
    Ann Surg Oncol. 2018 Apr 19. pii: 10.1245/s10434-018-6484.
    >> Share

  274. WEISER MR
    AJCC 8th Edition: Colorectal Cancer.
    Ann Surg Oncol. 2018 Apr 3. pii: 10.1245/s10434-018-6462.
    >> Share

  275. ZHOU H, Ruan C, Wang Z, Hu Z, et al
    Laparoscopic-Assisted Modified Intersphincter Resection for Ultralow Rectal Cancer.
    Ann Surg Oncol. 2018;25:947-948.
    >> Share

    March 2018
  276. SHIDA D, Yoshida T, Tanabe T, Tsukamoto S, et al
    Prognostic Impact of R0 Resection and Targeted Therapy for Colorectal Cancer with Synchronous Peritoneal Metastasis.
    Ann Surg Oncol. 2018 Mar 23. pii: 10.1245/s10434-018-6436.
    >> Share

  277. SIMONEAU E, Vauthey JN
    Progression of Colorectal Cancer Liver Metastasis After Chemotherapy: A New Test of Time?
    Ann Surg Oncol. 2018 Mar 19. pii: 10.1245/s10434-018-6439.
    >> Share

  278. FLAHERTY DC, Jalas JR, Sim MS, Stojadinovic A, et al
    The Negative Impact of Body Mass Index on the Tumor Microenvironment in Colon Cancer: Results of a Prospective Trial.
    Ann Surg Oncol. 2018 Mar 12. pii: 10.1245/s10434-018-6405.
    >> Share

  279. NAGATA H, Ishihara S, Oba K, Tanaka T, et al
    Development and Validation of a Prediction Model for Postoperative Peritoneal Metastasis After Curative Resection of Colon Cancer.
    Ann Surg Oncol. 2018 Mar 5. pii: 10.1245/s10434-018-6403.
    >> Share

  280. ARSONIADIS EG, Fan Y, Jarosek S, Gaertner WB, et al
    Decreased Use of Sphincter-Preserving Procedures Among African Americans with Rectal Cancer.
    Ann Surg Oncol. 2018;25:720-728.
    >> Share

  281. BLOK RD, Musters GD, Borstlap WAA, Buskens CJ, et al
    Snapshot Study on the Value of Omentoplasty in Abdominoperineal Resection with Primary Perineal Closure for Rectal Cancer.
    Ann Surg Oncol. 2018;25:729-736.
    >> Share

  282. STEWART CL, Gleisner A, Halpern A, Ibrahim-Zada I, et al
    Implications of Hyperthermic Intraperitoneal Chemotherapy Perfusion-Related Hyperglycemia.
    Ann Surg Oncol. 2018;25:655-659.
    >> Share

    February 2018
  283. HOPKINS JJ, Skubleny D, Bigam DL, Baracos VE, et al
    Barriers to the Interpretation of Body Composition in Colorectal Cancer: A Review of the Methodological Inconsistency and Complexity of the CT-Defined Body Habitus.
    Ann Surg Oncol. 2018 Feb 27. pii: 10.1245/s10434-018-6395.
    >> Share

  284. DHIR M, Zenati MS, Jones HL, Bartlett DL, et al
    Effectiveness of Hepatic Artery Infusion (HAI) Versus Selective Internal Radiation Therapy (Y90) for Pretreated Isolated Unresectable Colorectal Liver Metastases (IU-CRCLM).
    Ann Surg Oncol. 2018;25:550-557.
    >> Share

    January 2018
  285. ALI SM, Pawlik TM, Rodriguez-Bigas MA, Monson JRT, et al
    Timing of Surgical Resection for Curative Colorectal Cancer with Liver Metastasis.
    Ann Surg Oncol. 2018;25:32-37.
    >> Share

  286. PAQUETTE IM, Madoff RD, Sigurdson ER, Chang GJ, et al
    Impact of Proximal Vascular Ligation on Survival of Patients with Colon Cancer.
    Ann Surg Oncol. 2018;25:38-45.
    >> Share

  287. HUPKENS BJP, Maas M, Martens MH, van der Sande ME, et al
    Organ Preservation in Rectal Cancer After Chemoradiation: Should We Extend the Observation Period in Patients with a Clinical Near-Complete Response?
    Ann Surg Oncol. 2018;25:197-203.
    >> Share

    December 2017
  288. TAKAHASHI G, Yamada T, Iwai T, Takeda K, et al
    Oncological Assessment of Stent Placement for Obstructive Colorectal Cancer from Circulating Cell-Free DNA and Circulating Tumor DNA Dynamics.
    Ann Surg Oncol. 2017 Dec 12. pii: 10.1245/s10434-017-6300.
    >> Share

    November 2017
  289. CREASY JM, Sadot E, Koerkamp BG, Chou JF, et al
    The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer.
    Ann Surg Oncol. 2017 Nov 27. pii: 10.1245/s10434-017-6264.
    >> Share

  290. DURAES LC, Stocchi L, Steele SR, Kalady MF, et al
    The Relationship Between Clavien-Dindo Morbidity Classification and Oncologic Outcomes After Colorectal Cancer Resection.
    Ann Surg Oncol. 2017 Nov 7. doi: 10.1245/s10434-017-6142.
    >> Share

    October 2017
  291. TIERNAN JP, Jayne DG
    Antigen-Directed Cancer Surgery for Primary Colorectal Cancer: 15-Year Survival Analysis.
    Ann Surg Oncol. 2017 Oct 31. doi: 10.1245/s10434-017-6200.
    >> Share

  292. OH BY, Park YA, Huh JW, Yun SH, et al
    Prognostic Impact of Tumor-Budding Grade in Stages 1-3 Colon Cancer: A Retrospective Cohort Study.
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6135.
    >> Share

  293. POVOSKI SP, Hatzaras IS, Mojzisik CM, Arnold MW, et al
    Antigen-Directed Cancer Surgery for Primary Colorectal Cancer: 15-Year Survival Analysis: A Reply.
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6201.
    >> Share

  294. WATANABE K, Salah S, Saito N
    Comment on: Risk Factors for Survival After Lung Metastasectomy for Colorectal Cancer Patients.
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6199.
    >> Share

  295. BINAY SAFER V, Safer U, Yorulmaz E, Sahin Z, et al
    Comment: Skeletal Muscle Depletion is Associated with Severe Postoperative Complications in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Cancer.
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6166.
    >> Share

  296. KLAVER CEL, van Huijgevoort NCM, de Buck van Overstraeten A, Wolthuis AM, et al
    Locally Advanced Colorectal Cancer: True Peritoneal Tumor Penetration is Associated with Peritoneal Metastases.
    Ann Surg Oncol. 2017 Oct 26. doi: 10.1245/s10434-017-6037.
    >> Share

  297. PASSOT G, Kim BJ, Glehen O, Mehran RJ, et al
    Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter?
    Ann Surg Oncol. 2017 Oct 25. doi: 10.1245/s10434-017-6141.
    >> Share

  298. SHIDA D, Tsukamoto S, Ochiai H, Kanemitsu Y, et al
    Long-Term Outcomes After R0 Resection of Synchronous Peritoneal Metastasis from Colorectal Cancer Without Cytoreductive Surgery or Hyperthermic Intraperitoneal Chemotherapy.
    Ann Surg Oncol. 2017 Oct 23. doi: 10.1245/s10434-017-6133.
    >> Share

    September 2017
  299. CLARKE CN, Lee MS, Wei W, Manyam G, et al
    Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival.
    Ann Surg Oncol. 2017 Sep 21. doi: 10.1245/s10434-017-6054.
    >> Share

  300. DEMEY K, Wolthuis A, de Buck van Overstraeten A, Fieuws S, et al
    External Validation of the Prognostic Nomogram (COMPASS) for Patients with Peritoneal Carcinomatosis of Colorectal Cancer.
    Ann Surg Oncol. 2017 Sep 11. doi: 10.1245/s10434-017-6042.
    >> Share

    August 2017
  301. LORIMER PD, Motz BM, Kirks RC, Boselli DM, et al
    Pathologic Complete Response Rates After Neoadjuvant Treatment in Rectal Cancer: An Analysis of the National Cancer Database.
    Ann Surg Oncol. 2017;24:2095-2103.
    >> Share

  302. WHEALON MD, Gahagan JV, Sujatha-Bhaskar S, O'Leary MP, et al
    Is Fecal Diversion Needed in Pelvic Anastomoses During Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?
    Ann Surg Oncol. 2017;24:2122-2128.
    >> Share

  303. SCHNEIDER MA, Eshmuminov D, Lehmann K
    Major Postoperative Complications Are a Risk Factor for Impaired Survival after CRS/HIPEC.
    Ann Surg Oncol. 2017;24:2224-2232.
    >> Share

  304. SEEBERG LT, Brunborg C, Waage A, Hugenschmidt H, et al
    Survival Impact of Primary Tumor Lymph Node Status and Circulating Tumor Cells in Patients with Colorectal Liver Metastases.
    Ann Surg Oncol. 2017;24:2113-2121.
    >> Share

    June 2017
  305. YAMASHITA S, Sakamoto Y, Yamamoto S, Takemura N, et al
    Efficacy of Preoperative Portal Vein Embolization Among Patients with Hepatocellular Carcinoma, Biliary Tract Cancer, and Colorectal Liver Metastases: A Comparative Study Based on Single-Center Experience of 319 Cases.
    Ann Surg Oncol. 2017;24:1557-1568.
    >> Share

  306. LIM TZ, Chan DKH, Tan KK
    Endoscopic Stenting Does Not Worsen Long Term Outcomes Amongst Patients Presenting with Obstruction from Colorectal Cancers.
    Ann Surg Oncol. 2017;24:1618-1625.
    >> Share

    May 2017
  307. HAWKINS AT, Wells KO, Krishnamurty DM, Hunt SR, et al
    Preoperative Chemotherapy and Survival for Large Anorectal Gastrointestinal Stromal Tumors: A National Analysis of 333 Cases.
    Ann Surg Oncol. 2017;24:1195-1201.
    >> Share

  308. ACHARYA A, Markar SR, Matar M, Ni M, et al
    Use of Tumor Markers in Gastrointestinal Cancers: Surgeon Perceptions and Cost-Benefit Trade-Off Analysis.
    Ann Surg Oncol. 2017;24:1165-1173.
    >> Share

  309. VYCHNEVSKAIA K, Dumont F, Agostini J, Julie C, et al
    Prognostic Value of Sterilized Lymph Nodes After Preoperative Chemoradiotherapy for Patients with ypN0 Rectal Cancer.
    Ann Surg Oncol. 2017;24:1304-1311.
    >> Share

  310. YAMASHITA S, Loyer E, Kang HC, Aloia TA, et al
    Total Transthoracic Approach Facilitates Laparoscopic Hepatic Resection in Patients with Significant Prior Abdominal Surgery.
    Ann Surg Oncol. 2017;24:1376-1377.
    >> Share

  311. DREYER SB, Powell AG, McSorley ST, Waterston A, et al
    The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal Cancer.
    Ann Surg Oncol. 2017;24:1295-1303.
    >> Share

  312. KULAYLAT AS, Hollenbeak CS, Stewart DB Sr
    Adjuvant Chemotherapy Improves Overall Survival of Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy Regardless of Pathologic Nodal Status.
    Ann Surg Oncol. 2017;24:1281-1288.
    >> Share

    April 2017
  313. CHOULIARAS K, Levine EA, Fino N, Shen P, et al
    Prognostic Factors and Significance of Gastrointestinal Leak After Cytoreductive Surgery (CRS) with Heated Intraperitoneal Chemotherapy (HIPEC).
    Ann Surg Oncol. 2017;24:890-897.
    >> Share

  314. DHIR M, Ramalingam L, Shuai Y, Pakrafter S, et al
    Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Adolescent and Young Adults with Peritoneal Metastases.
    Ann Surg Oncol. 2017;24:875-883.
    >> Share

  315. CHAN CH, Liesenfeld LF, Ferreiro-Neira I, Cusack JC Jr, et al
    Preclinical Evaluation of Cathepsin-Based Fluorescent Imaging System for Cytoreductive Surgery.
    Ann Surg Oncol. 2017;24:931-938.
    >> Share

  316. MEHTA AM, Huitema AD, Burger JW, Brandt-Kerkhof AR, et al
    Standard Clinical Protocol for Bidirectional Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Systemic Leucovorin, 5-Fluorouracil, and Heated Intraperitoneal Oxaliplatin in a Chloride-Containing Carrier Solution.
    Ann Surg Oncol. 2017;24:990-997.
    >> Share

  317. IHEMELANDU C
    Inflammation-Based Prognostic Scores: Utility in Prognostication and Patient Selection for Cytoreduction and Perioperative Intraperitoneal Chemotherapy in Patients with Peritoneal Metastasis of Colonic Origin.
    Ann Surg Oncol. 2017;24:884-889.
    >> Share

  318. IHEMELANDU C, Sugarbaker PH
    Management for Peritoneal Metastasis of Colonic Origin: Role of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: A Single Institution's Experience During Two Decades.
    Ann Surg Oncol. 2017;24:898-905.
    >> Share

  319. WRIGHT GP, Marsh JW, Varma MK, Doherty MG, et al
    Liver Resection After Selective Internal Radiation Therapy with Yttrium-90 is Safe and Feasible: A Bi-institutional Analysis.
    Ann Surg Oncol. 2017;24:906-913.
    >> Share

  320. VIGANO L, Lopci E, Costa G, Rodari M, et al
    Positron Emission Tomography-Computed Tomography for Patients with Recurrent Colorectal Liver Metastases: Impact on Restaging and Treatment Planning.
    Ann Surg Oncol. 2017;24:1029-1036.
    >> Share

  321. MACHADO MA, Surjan R, Basseres T, Makdissi F, et al
    Total Laparoscopic Reversal ALPPS.
    Ann Surg Oncol. 2017;24:1048-1049.
    >> Share

    March 2017
  322. WAITE K, Youssef H
    The Role of Neoadjuvant and Adjuvant Systemic Chemotherapy with Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Systematic Review.
    Ann Surg Oncol. 2017;24:705-720.
    >> Share

  323. THORGERSEN EB, Goscinski MA, Spasojevic M, Solbakken AM, et al
    Deep Pelvic Surgical Site Infection After Radiotherapy and Surgery for Locally Advanced Rectal Cancer.
    Ann Surg Oncol. 2017;24:721-728.
    >> Share

    February 2017
  324. LEE DY, Teng A, Pedersen RC, Tavangari FR, et al
    Racial and Socioeconomic Treatment Disparities in Adolescents and Young Adults with Stage II-III Rectal Cancer.
    Ann Surg Oncol. 2017;24:311-318.
    >> Share

  325. CHOI SH, Choi GH, Han DH, Kwon SW, et al
    Laparoscopic Right Hepatectomy: Toward Protocolization and Simplification.
    Ann Surg Oncol. 2017;24:554-555.
    >> Share

    January 2017
  326. SIOULAS VD, Jorge S, Chern JY, Schiavone MB, et al
    Robotically Assisted Laparoscopic Ovarian Transposition in Women with Lower Gastrointestinal Cancer Undergoing Pelvic Radiotherapy.
    Ann Surg Oncol. 2017;24:251-256.
    >> Share

  327. WIMMER K, Schwarz C, Szabo C, Bodingbauer M, et al
    Impact of Neoadjuvant Chemotherapy on Clinical Risk Scores and Survival in Patients with Colorectal Liver Metastases.
    Ann Surg Oncol. 2017;24:236-243.
    >> Share

  328. BEPPU N, Kimura F, Aihara T, Doi H, et al
    Patterns of Local Recurrence and Oncologic Outcomes in T3 Low Rectal Cancer (</=5 cm from the Anal Verge) Treated With Short-Course Radiotherapy With Delayed Surgery : Outcomes in T3 Low Rectal Cancer Treated With Short-Course Radiotherapy With Del
    Ann Surg Oncol. 2017;24:219-226.
    >> Share

  329. MARGONIS GA, Sasaki K, Andreatos N, Kim Y, et al
    KRAS Mutation Status Dictates Optimal Surgical Margin Width in Patients Undergoing Resection of Colorectal Liver Metastases.
    Ann Surg Oncol. 2017;24:264-271.
    >> Share

  330. DHIR M, Jones HL, Shuai Y, Clifford AK, et al
    Hepatic Arterial Infusion in Combination with Modern Systemic Chemotherapy is Associated with Improved Survival Compared with Modern Systemic Chemotherapy Alone in Patients with Isolated Unresectable Colorectal Liver Metastases: A Case-Control Study.
    Ann Surg Oncol. 2017;24:150-158.
    >> Share

  331. ORCUTT ST, Massarweh NN, Li LT, Artinyan A, et al
    Patterns of Care for Colorectal Liver Metastasis Within an Integrated Health System: Secular Trends and Outcomes.
    Ann Surg Oncol. 2017;24:23-30.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016